# Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Mechanically Ventilated ICU Patients

> **NCT04790734** · PHASE2 · COMPLETED · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 60 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Sedation drugs

## Key facts

- **NCT ID:** NCT04790734
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-05-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790734, "Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Mechanically Ventilated ICU Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04790734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
